美国联邦法官拒绝诺华公司阻止MSN制药公司推出通用药物Entresto. US federal judge denies Novartis' bid to block generic Entresto launch by MSN Pharmaceuticals.
一位美国联邦法官裁定非专利药商MSN制药公司(MSNPI)胜出后, 诺华公司失去了阻止推出其畅销心衰药(Entresto)的通用版本的投标。 Novartis lost its bid to block the launch of a generic version of its best-selling heart-failure drug, Entresto, after a US federal judge ruled in favor of generic drugmaker MSN Pharmaceuticals (MSNPI). Novartis未能使法院相信,MSNPI的产品侵犯了其专利权,法官说,停止MSNPI的通用发射是没有道理的。 Novartis failed to convince the court that MSNPI's product infringed on its patents, with the judge stating that stopping MSNPI's generic launch was not justified. 法官下令暂时停止72小时,诺瓦尔蒂斯则前往美国上诉法院寻求禁止令。 The judge ordered a temporary 72-hour halt while Novartis goes to the US Court of Appeal to seek an injunction. 诺华公司在华盛顿特区的联邦法院提起诉讼, 声称FDA对通用版本的Entresto的批准是非法的. Novartis separately filed a lawsuit with a federal court in Washington, D.C., claiming the FDA's approval of a generic version of Entresto is unlawful.